Source: VC News Daily

Thesis: Thesis Announces $13.5M Seed and Series A

NEW YORK, NY, Thesis, the company that offers a customized approach to cognitive performance products based on your unique brain chemistry, has raised over $13.5 million in funding.

Read full article »

Thesis's Competitors | Thesis's News | Thesis's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Founder & CEO

Dan Freed

CEO Approval Rating

90/100

Thesis is a New York-based nootropics company that formulates and commercializes personalized brain health supplements and cognitive performance products for individuals.